Yoann PRADAT

Cited by

	All	Since 2019
Citations	244	244
h-index	6	6
i10-index	5	5

140

105

20222023202418 134 92

Public access

View all

5 articles

0 articles

available

not available

Based on funding mandates

Co-authors

fabrice andreUniversité Paris SudVerified email at igr.fr
Stefan MichielsOffice Biostatistics & Epidemiology, Gustave Roussy; Oncostat, Univ. Paris Saclay, INSERMVerified email at gustaveroussy.fr
Tran Duc HuyAssociate Professor - Dr. of Materials Science, Hanoi University of Science and TechnologyVerified email at hust.edu.vn
Amélie LUSQUEBiostatistician, Institut Claudius RegaudVerified email at iuct-oncopole.fr
Thomas BachelotCentre Léon BérardVerified email at lyon.unicancer.fr
Pr. Paul-Henry CournèdeLab of Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-SaclayVerified email at ecp.fr
loriot yGustave RoussyVerified email at gustaveroussy.fr
Sergey NikolaevGustave RoussyVerified email at gustaveroussy.fr
Antoine HollebecqueConsultant, Gustave Roussy Cancer Campus, VillejuifVerified email at gustaveroussy.fr
luc fribouletGustave Roussy Université Paris SaclayVerified email at gustaveroussy.fr
Véronique CHUNG SCOTTVerified email at igr.fr
Guillaume GrisayUclouvainVerified email at jolimont.be
Daniel GautheretProfessor. Computational Biology, Université Paris-SaclayVerified email at u-psud.fr
padioleau ismaëlIGH MontpellierVerified email at igr.fr
Laura MezquitaHospital Clinic - IDIBAPS, Barcelona, SpainVerified email at clinic.cat
Andrey YurchenkoGustave Roussy Cancer CenterVerified email at gustaveroussy.fr
Loic VerlingueCentre Léon Bérard, CRCL, U1030Verified email at lyon.unicancer.fr
Konstantin V GunbinVerified email at kantiana.ru
Hakim BenkiraneUniversité Paris-SaclayVerified email at centralesupelec.fr
Francesco FacchinettiDana-Farber Cancer InstituteVerified email at dfci.harvard.edu

Yoann PRADAT

Gustave Roussy

Verified email at gustaveroussy.fr

Computational Biology Applied Statistics Genetics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Unified classification and risk-stratification in Acute Myeloid Leukemia Y Tazi, JE Arango-Ossa, Y Zhou, E Bernard, I Thomas, A Gilkes, ... Nature Communications 13 (1), 4622, 2022	80	2022
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial F Mosele, E Deluche, A Lusque, L Le Bescond, T Filleron, Y Pradat, ... Nature Medicine 29 (8), 2110-2120, 2023	66	2023
LBA72 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial MF Mosele, A Lusque, VC Dieras, E Deluche, A Ducoulombier, B Pistilli, ... Annals of Oncology 33, S1440, 2022	54	2022
Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer Y Pradat, J Viot, AA Yurchenko, K Gunbin, L Cerbone, M Deloger, ... Cancer Discovery 13 (5), 1116-1143, 2023	16	2023
CustOmics: A versatile deep-learning based strategy for multi-omics integration H Benkirane, Y Pradat, S Michiels, PH Cournède PLOS Computational Biology 19 (3), e1010921, 2023	13	2023
Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer F Facchinetti, A Hollebecque, F Braye, D Vasseur, Y Pradat, R Bahleda, ... Cancer discovery 13 (9), 1998-2011, 2023	9	2023
Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer: the DAISY trial F Andre, M Fernanda, E Deluche, A LUSQUE, L Le-Bescond, T Filleron, ...	6	2022

The system can't perform the operation now. Try again later.

Articles 1–7

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors